tiprankstipranks
Trending News
More News >
Pharming Group Nv (PHAR)
NASDAQ:PHAR
US Market

Pharming Group (PHAR) Financial Statements

Compare
197 Followers

Pharming Group Financial Overview

Pharming Group's market cap is currently $1.19B. The company's EPS TTM is $0.1; its P/E ratio is 1,166.67; Pharming Group is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $0.01. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue€ 297.20M€ 245.32M€ 205.62M€ 198.87M€ 212.17M
Gross Profit€ 261.80M€ 220.10M€ 188.06M€ 177.73M€ 188.63M
Operating Income€ -8.62M€ -5.39M€ 18.23M€ 13.56M€ 76.26M
EBITDA€ 16.32M€ 9.88M€ 33.53M€ 48.78M€ 58.35M
Net Income€ -11.84M€ -10.55M€ 13.67M€ 16.00M€ 37.75M
Balance Sheet
Cash & Short-Term Investments€ 167.89M€ 213.42M€ 207.34M€ 191.92M€ 167.94M
Total Assets€ 399.99M€ 462.85M€ 425.80M€ 397.31M€ 342.55M
Total Debt€ 112.31M€ 171.54M€ 166.69M€ 161.76M€ 132.58M
Net Debt€ 57.37M€ 109.80M€ -40.65M€ -30.16M€ -35.36M
Total Liabilities€ 178.92M€ 244.07M€ 221.16M€ 204.40M€ 192.39M
Stockholders' Equity€ 221.06M€ 218.78M€ 204.64M€ 192.92M€ 150.16M
Cash Flow
Free Cash Flow€ -2.59M€ -18.77M€ 20.48M€ 21.13M€ 68.33M
Operating Cash Flow€ -1.79M€ -17.30M€ 22.46M€ 37.84M€ 83.63M
Investing Cash Flow€ 31.62M€ -129.39M€ 5.32M€ -21.30M€ -15.63M
Financing Cash Flow€ -34.41M€ -1.04M€ -4.98M€ -27.95M€ 60.69M
Currency in EUR

Pharming Group Earnings and Revenue History

Pharming Group Debt to Assets

Pharming Group Cash Flow

Pharming Group Forecast EPS vs Actual EPS